25-OCH3-PPD induces the apoptosis of activated t-HSC/Cl-6 cells via c-FLIP-mediated NF-κB activation

Chemico-Biological Interactions

Volumn 194, Issue 2-3, 2011, Pages 106-112

  Wu, Yan Ling ^a   Wan, Ying ^a   Jin, Xue Jun ^a   Ouyang, Bing Qing ^a   Bai, Ting ^a   Zhao, Yu Qing ^b   Nan, Ji Xing ^a  

^a YANBIAN UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

25 OCH3 PPD; Anti fibrosis; Apoptosis; c FLIP; NF B

Indexed keywords

25 METHOXYLDAMMARANE 3BETA,12BETA,20 TRIOL; ALPHA SMOOTH MUSCLE ACTIN; ANTIFIBROTIC AGENT; CASPASE 3; FLICE INHIBITORY PROTEIN; GLUTATHIONE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; SAPOGENIN; SURVIVIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; CFLAR PROTEIN, MOUSE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBROSIS; GINSENG; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANAX NOTOGINSENG; SIGNAL TRANSDUCTION; STELLATE CELL; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECT; LIVER CELL; METABOLISM; PHYSIOLOGY; WESTERN BLOTTING;

PANAX GINSENG; PANAX NOTOGINSENG;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL LINE; GLUTATHIONE; HEPATOCYTES; HUMANS; MICE; NF-KAPPA B; SAPOGENINS; SIGNAL TRANSDUCTION;

EID: 80054055472     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2011.08.010     Document Type: Article

References (30)

1. S.L. Friedman Liver fibrosis: from bench to bedside J. Hepatol. 38 2003 S38 S53
2. R. Bataller, and D.A. Brenner Liver fibrosis J. Clin. Invest. 115 2005 209 218 (Pubitemid 40385459)
3. S. Lotersztajn, B. Julien, F. Teixeira-Clerc, P. Grenard, and A. Mallat Hepaticfibrosis: molecular mechanisms and drug targets Ann. Rev. Pharmacol. Toxicol. 45 2005 605 628 (Pubitemid 40261819)
4. S.L. Friedman Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies N. Engl. J. Med. 328 1993 1828 1835 (Pubitemid 23174715)
5. S.L. Friedman Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury J. Biol. Chem. 275 2000 2247 2250 (Pubitemid 30081976)
6. R.F. McGuire, D.M. Bissell, J. Boyles, and F.J. Roll Role of extracellular matrix in regulating fenestrations of sinusoidal endothelial cells isolated from normal rat liver Hepatology 15 1992 989 997
7. R.C. Benyon, and M.J. Arthur Extracellular matrix degradation and the role of stellate cells Semin. Liver Dis. 21 2001 373 384 (Pubitemid 32923766)
8. A.J. Czaja, and H.A. Carpenter Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis J. Hepatol. 40 2004 646 652 (Pubitemid 38367787)
9. Y. Zhao, W. Wang, L. Han, E.R. Rayburn, D.L. Hill, H. Wang, and R. Zhang Isolation, structural determination, and evaluation of the biological activity of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol [20(S)-25-OCH3-PPD], a novel natural product from Panax notoginseng Med. Chem. 3 2007 51 60 (Pubitemid 46062342)
10. X.L. Bi, Y.Q. Zhao, W.F. Fang, and W.C. Yang Anticancer activity of Panax notoginseng extract 20(s)-25-OCH3-PPD: targeting β-catenin signaling Clin. Exp. Pharmacol. Physiol. 36 2009 1074 1078
11. W. Wang, Y. Zhao, E.R. Rayburn, D.L. Hill, H. Wang, and R. Zhang In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng Cancer Chemother. Pharmacol. 59 2006 589 601 (Pubitemid 46295123)
12. W. Wang, H. Wang, E.R. Rayburn, Y. Zhao, D.L. Hill, and R. Zhang 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol. A novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action Br. J. Cancer 98 2008 792 802 (Pubitemid 351272613)
13. T.A. Wynn Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases J. Clin. Invest. 117 2007 524 529 (Pubitemid 46348506)
14. S.L. Friedman Hepatic stellate cells: protean, multifunctional and enigmatic cells of the liver Physiol. Rev. 88 2008 125 172
15. E. Olaso, and S.L. Friedman Molecular regulation of hepatic fibrogenesis J. Hepatol. 29 1998 836 847 (Pubitemid 28505945)
16. K.S. Lee, M. Buck, K. Houglum, and M. Chojkier Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression J. Clin. Invest. 96 1995 2461 2468
17. P. Greenwel, J.A. Dominguez-Rosales, G. Mavi, A.M. Rivas-Estilla, and M. Rojkind Hydrogen peroxide: a link between acetaldehyde-elicited alpha1(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells Hepatology 31 2000 109 116 (Pubitemid 30033696)
18. M.F. Tsan, J.E. White, and C.L. Rosano Modulation of endothelial GSH concentrations: effect of exogenous GSH and GSH monoethyl ester J. Appl. Physiol. 66 1989 1029 1034 (Pubitemid 19091324)
19. G. Wu, Y.Z. Fang, S. Yang, J.R. Lupton, and N.D. Turner Glutathione metabolism and its implications for health J. Nutr. 134 2004 489 492 (Pubitemid 38298485)
20. M.C. Myhrstad, H. Carlsen, O. Nordstrom, R. Blomhoff, and J.O. Moskaug Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter Free Radic. Biol. Med. 32 2002 386 393 (Pubitemid 34178348)
21. A. Krueger, I. Schmitz, S. Baumann, P.H. Krammer, and S. Kirchhoff Cellular fl ice-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the cd95 death-inducing signaling complex J. Biol. Chem. 276 2001 20633 20640
22. C. Scaffidi, I. Schmitz, P.H. Krammer, and M.E. Peter The role of c-FLIP in modulation of CD95-induced apoptosis J. Biol. Chem. 274 1999 1541 1548
23. M. Thome, P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J.L. Bodmer, and M. Schröter Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors Nature 386 1997 517 521 (Pubitemid 27164081)
24. T. Kataoka, R.C. Budd, N. Holler, M. Thome, F. Martinon, M. Irmler, and K. Burns The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways Curr. Biol. 10 2000 640 648 (Pubitemid 30354699)
25. W.H. Hu, H. Johnson, and H.B. Shu Activation of NF-kappaB by FADD, Casper, and caspase-8 J. Biol. Chem. 275 2000 10838 10844 (Pubitemid 30212715)
26. M. Thome, and J. Tschopp Regulation of lymphocyte proliferation and death by FLIP Nat. Rev. Immunol. 1 2001 50 58 (Pubitemid 33741975)
27. S. Ghosh, and M. Karin Missing pieces in the NF-kappaB puzzle Cell 109 2002 S81 S96
28. M.S. Hayden, and S. Ghosh Signaling to NF-kappaB Genes Dev. 18 2004 2195 2224
29. J. Hinshaw-Makepeace, G. Huston, K.A. Fortner, J.Q. Russell, D. Holoch, S. Swain, and R.C. Budd C-FLIP(S) reduces activation of caspase and NF-kappaB pathways and decreases T cell survival Eur. J. Immunol. 38 2008 54 63
30. A. Golks, D. Brenner, P.H. Krammer, and I.N. Lavrik The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation J. Exp. Med. 203 2006 1295 1305 (Pubitemid 43736598)